Bibliografía
Referencias Bibliográficas
1. Brines M, Ghezzi P, Keenan S et al. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. PNAS 2000:97: 10526-10531.
2. Genc S, Kuralay F, Genc K et al. Erythropoietin exerts neuroprotection in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57/BL mice via increasing nitric oxide production. Neurosci Lett 2001:298: 139-141.
3. Ehrenreich H, Timner W, Siren AL. A novel role for an established player: anemia drug erythropoietin for the treatment of cerebral hypoxia/ischemia. Transfus Apher Sci 2004:31: 39-44.
4. Ehrenreich H, Hasselblatt M, Dembowski C et al. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 2002:8: 495-505.
5. Erbayraktar S, Grasso G, Sfacteria A et al. Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo. Proc Natl Acad Sci U S A 2003:100: 6741-6746.
6. Graff CL, Pollack GM. Nasal drug administration: potential for targeted central nervous system delivery. J Pharm Sci 2005:94: 1187-1195.
7. Illum L. Nasal drug delivery--possibilities, problems and solutions. J Control Release 2003:87: 187-198.
8. Illum L. Nasal drug delivery: new developments and strategies. Drug Discov Today 2002:7: 1184-1189.
9. Traystman RJ. Animal Models of Focal and Global Cerebral Ischemia. ILAR Journal 2003:44: 85-95.
10. Sakanaka M, Wen T-C, Matsuda S et al. In vivo evidence that erythropoietin protects neurons from ischemic damage. PNAS 1998:95: 4635-4640.
11. Cheng B, Mattson MP. PDGFs protect hippocampal neurons against energy deprivation and oxidative injury: evidence for induction of antioxidant pathways. J Neurosci 1995:15: 7095-7104.
12. ILAR. Guide for the Care and Use of Laboratory Animals. Washington , D.C.: National Academy Press,1996.
13. Muñoz Cernuda, A., León Rodríguez, R., García Rodríguez, J. C., Nuñez Figueredo, Y., Pardo Ruiz, Z., García Salman, J. D., Sosa, I., Curbelo Rodríguez, D., Cruz Rodríguez, J., and Subiros Martínez, N. Formulaciones nasales de EPOhr con bajo contenido de ácido siálico para el tratamiento de enfermedades del Sistema Nervioso Central. (20050138). 22-7-0005. Cuba. Ref Type: Patent
14. Buterfield JD, Mcgraw CP. Efect of the DPPD (diphenyl-para-phenylendiamine) on stroke and cerebral edema in gerbils. Stroke 1978:9.
15. Lawner P, Laurent J, Simeone F, Fink E, Rubin E. Attenuation of ischemic brain edema by pentobarbital after carotid ligation in the gerbil. Stroke 1979:10: 644-647.
16. Colbourne F, Auer RN, Sutherland GR. Behavioral testing does not exacerbate ischemic CA1 damage in gerbils. Stroke 1998:29: 1967-1970.
17. Loskota WJ, Lomax P, Verity MA. A stereotaxic atlas of the Mongolian gerbil brain (Meriones unguiculatus). Los Angeles, California: Ann Arbor Science,1973.
18. Rasband, W. ImageJ. (1.34s). 2006. National Institutes of Health,USA. Ref Type: Computer Program
19. Brown AW. Structural abnormalities in neurones. J Clin Pathol Suppl (R Coll Pathol ) 1977:11:155-69.: 155-169.
20. Laidley DT, Colbourne F, Corbett D. Increased behavioral and histological variability arising from changes in cerebrovascular anatomy of the Mongolian gerbil. Curr Neurovasc Res 2005:2: 401-407.
21. Kitagawa K, Matsumoto M, Kuwabara K et al. 'Ischemic tolerance' phenomenon detected in various brain regions. Brain Res 1991:561: 203-211.
22. Catania MA, Marciano MC, Parisi A et al. Erythropoietin prevents cognition impairment induced by transient brain ischemia in gerbils. Eur J Pharmacol 2002:437: 147-150.
23. Calapai G, Marciano MC, Corica F et al. Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation. Eur J Pharmacol 2000:401: 349-356.
24. Wen TC, Sadamoto Y, Tanaka J et al. Erythropoietin protects neurons against chemical hypoxia and cerebral ischemic injury by up-regulating Bcl-xL expression. J Neurosci Res 2002:67: 795-803.
25. Harukuni I, Bhardwaj A. Mechanisms of brain injury after global cerebral ischemia. Neurol Clin 2006:24: 1-21.
26. Lipton P. Ischemic cell death in brain neurons. Physiol Rev 1999:79: 1431-1568.
27. Kirino T, Sano K. Selective vulnerability in the gerbil hippocampus following transient ischemia. Acta Neuropathol (Berl) 1984:62: 201-208.
28. Kirino T, Sano K. Fine structural nature of delayed neuronal death following ischemia in the gerbil hippocampus. Acta Neuropathol (Berl) 1984:62: 209-218.
29. Colbourne F, Corbett D. Delayed and prolonged post-ischemic hypothermia is neuroprotective in the gerbil. Brain Res 1994:654: 265-272.
30. Ishibashi S, Kuroiwa T, Endo S, Okeda R, Mizusawa H. A comparison of long-term neurological symptoms after two different focal ischemic models in Mongolian gerbils. Acta Neurochir Suppl 2003:86:159-62.: 159-162.
31. Sugawara T, Fujimura M, Noshita N et al. Neuronal death/survival signaling pathways in cerebral ischemia. NeuroRx 2004:1: 17-25.
32. García Salman JD. Protección neuronal endógena: un enfoque alternativo. Revista de Neurología 2004:38: 150-155.
33. Dirnagl U, Simon RP, Hallenbeck JM. Ischemic tolerance and endogenous neuroprotection. Trends Neurosci 2003:26: 248-254.
34. Kern RC, Conley DB, Haines GK, Robinson AM. Pathology of the Olfactory Mucosa: Implications for the Treatment of Olfactory Dysfunction. The Laryngoscope 2006:114: 279-285.
35. Banks AW. Are the extracelular pathways a conduit for the delivery of therapeutics to the brain? Current Pharmaceutical Design 2004:10: 1365-1370.
36. Liu XF, Fawcett JR, Thorne RG, Frey WH. Non-invasive intranasal insulin-like growth factor-I reduces infarct volume and improves neurologic function in rats following middle cerebral artery occlusion. Neurosci Lett 2001:308: 91-94.
37. Yu Y-P, Xu Q-Q, Zhang Q, Zhang W-P, Zhang L-H, Wei E-Q. Intranasal recombinant human erythropoietin protects rats against focal cerebral ischemia. Neuroscience Letters 2005:387: 5-10.
38. Sosa I, García Rodríguez JC, Santana J et al. Intranasal administration of recombinant human Erythropoietin exerts neuroprotective effects on post-ischemic brain injury in Mongolian gerbils. Pharmacologyonline 2006:1: 100-112.
39. Subiros Martínez, N., García Rodríguez, J. C., González Navarro, B., Sosa, I., and García Salman, J. D. Evaluación histológica del efecto de la Eritropoyetina vía intranasal, sobre la muerte neuronal retardada en gerbos sometidos a isquemia cerebral transitoria. Estudio preliminar. VII Congreso Virtual Hispanoamericano de Anatomía Patológica . 2005. Ref Type: Electronic Citation
|